Comorbid generalized anxiety disorder and its association with quality of life in patients with major depressive disorder

Yongjie Zhou, Zhongqiang Cao, Mei Yang, Xiaoyan Xi, Yiyang Guo, Maosheng Fang, Lijuan Cheng, Yukai Du, Yongjie Zhou, Zhongqiang Cao, Mei Yang, Xiaoyan Xi, Yiyang Guo, Maosheng Fang, Lijuan Cheng, Yukai Du

Abstract

The comorbidity of major depressive disorder (MDD) and generalized anxiety disorder (GAD) is common and often predicts poorer outcomes than either disorder alone. This study aimed to examine the prevalence of comorbid GAD and its association with quality of life (QOL) among MDD patients. A total of 1225 psychiatric outpatients were screened using the Hospital Anxiety and Depression Scale (HADS). Those who scored ≥8 on the HADS were interviewed using DSM-IV criteria by two senior psychiatrists. Patients diagnosed with MDD were further assessed using the 9-item Patient Health Questionnaire, Social Support Rating Scale, Pittsburgh Sleep Quality Index, and World Health Organization QOL Scale, brief version (WHOQOL-BREF). Ultimately, 667 patients were diagnosed with MDD, of 71.7% of whom had GAD. Compared to those with MDD alone, comorbid patients had lower scores on the physical (38.64 ± 10.35 vs.36.54 ± 12.32, P = 0.026) and psychological (35.54 ± 12.98 vs. 30.61 ± 14.66, P < 0.001) domains of the WHOQOL-BREF. The association between comorbid GAD and poor QOL on the two domains remained statistically significant in the multiple linear regression (unstandardized coefficients: -1.97 and -4.65, P < 0.001). In conclusion, the prevalence of comorbid GAD in MDD patients is high, and co-occurring GAD may exacerbate impaired physical and psychological QOL in Chinese MDD patients.

References

    1. Kessler R. C., Merikangas K. R. & Wang P. S. Prevalence, comorbidity, and service utilization for mood disorders in the United States at the beginning of the twenty-first century. Annu Rev Clin Psychol. 3, 137–158 (2007).
    1. Gao K. et al.. Should an assessment of Axis I comorbidity be included in the initial diagnostic assessment of mood disorders? Role of QIDS-16-SR total score in predicting number of Axis I comorbidity. J Affect Disord. 148, 256–264 (2013).
    1. Moscati A., Flint J. & Kendler K. S. Classification of anxiety disorders comorbid with major depression: common or distinct influencces on risk? Depress Anxiety. 33, 120–127 (2016).
    1. Kessler R. C. et al.. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). Jama. 289, 3095–3105 (2003).
    1. Carter R. M., Wittchen H. U., Pfister H. & Kessler R. C. One-year prevalence of subthreshold and threshold DSM-IV generalized anxiety disorder in a nationally representative sample. Depress Anxiety. 13, 78–88 (2001).
    1. Brown T. A., Campbell L. A., Lehman C. L., Grisham J. R. & Mancill R. B. Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample. J Abnorm Psychol. 110, 585–599 (2001).
    1. Lamers F. et al.. Comorbidity patterns of anxiety and depressive disorders in a large cohort study: the Netherlands Study of Depression and Anxiety (NESDA). J Clin Psychiatry. 72, 341–348 (2011).
    1. Albert U., Rosso G., Maina G. & Bogetto F. Impact of anxiety disorder comorbidity on quality of life in euthymic bipolar disorder patients: differences between bipolar I and II subtypes. J Affect Disord. 105, 297–303 (2008).
    1. Hofmeijer-Sevink M. K. et al.. Clinical relevance of comorbidity in anxiety disorders: a report from the Netherlands Study of Depression and Anxiety (NESDA). J Affect Disord. 137, 106–112 (2012).
    1. Johansson R., Carlbring P., Heedman A., Paxling B. & Andersson G. Depression, anxiety and their comorbidity in the Swedish general population: point prevalence and the effect on health-related quality of life. PeerJ. 1, e98–115 (2013).
    1. D’Avanzato C. et al.. Anxiety symptoms among remitted depressed outpatients: prevalence and association with quality of life and psychosocial functioning. J Affect Disord. 151, 401–404 (2013).
    1. Cyranowski J. M. et al.. Psychosocial features associated with lifetime comorbidity of major depression and anxiety disorders among a community sample of mid-life women: the SWAN mental health study. Depress Anxiety. 29, 1050–1057 (2012).
    1. Loo H. M., Schoevers R. A., Kendler K. S., Jonge P. & Romeijn J. W. Psychiatric comorbidity does not only depend on diagnostic thresholds: an illustration with major depressive disorder and generalized anxiety disorder. Depress Anxiety. 33, 143–152 (2015).
    1. Nock M. K., Hwang I., Sampson N. A. & Kessler R. C. Mental disorders, comorbidity and suicidal behavior: results from the National Comorbidity Survey Replication. Mol Psychiatry. 15, 868–876 (2010).
    1. Jin H., Wu S., Vidyanti I., Di Capua P. & Wu B. Predicting depression among patients with diabetes using longitudinal data. a multilevel regression model. Methods Inf Med. 54, 553–559 (2015).
    1. Shi Z. X. et al.. The research on clinical characteristics of comorbid anxiety and depression disorders. Shanghai Archives of Psychiatry. 04, 198–202 (2009).
    1. Carin J. Meijer, Maarten W. J. Koeter, Mirjam A. G. Sprangers & Schene A. H. Predictors of general quality of life and the mediating role of health related quality of life in patients with schizophrenia. Social Psychiatry. 44, 361–368 (2008).
    1. Zilcha-Mano S., Dinger U., McCarthy K. S., Barrett M. S. & Barber J. P. Changes in well-being and quality of life in a randomized trial comparing dynamic psychotherapy and pharmacotherapy for major depressive disorder. J Affect Disord. 152–154, 538–542 (2014).
    1. Rubio J. M. et al.. Effect of first episode axis I disorders on quality of life. J Nerv Ment Dis. 202, 271–274 (2014).
    1. Fleury M. J. et al.. Predictors of quality of life in a longitudinal study of users with severe mental disorders. Health Qual Life Outcomes. 11, 92 (2013).
    1. Alonso J. et al.. Disability and quality of life impact of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand Suppl. 420, 38–46 (2004).
    1. Rapaport M. H., Clary C., Fayyad R. & Endicott J. Quality-of-life impairment in depressive and anxiety disorders. Am J Psychiatry. 162, 1171–1178 (2005).
    1. Bonicatto S., Dew M., Zaratiegui R., Lorenzo L. & Pecina P. Adult outpatients with depression: worse quality of life than in other chronic medical diseases in Argentina. Soc Sci Med. 52, 911–919 (2001).
    1. Olatunji B. O., Cisler J. M. & Tolin D. F. Quality of life in the anxiety disorders: a meta-analytic review. Clin Psychol Rev. 27, 572–581 (2007).
    1. Dalgard O. S., Bjork S. & Tambs K. Social support, negative life events and mental health. The British Br J Psychiatry. 166(1), 29–34 (1995).
    1. Avenevoli S., Swendsen J., He J. P., Burstein M. & Merikangas K. R. Major depression in the national comorbidity survey-adolescent supplement: prevalence, correlates, and treatment. J Am Acad Child Adolesc Psychiatry. 54, 37–44.e32 (2015).
    1. Woo J. M. et al.. Importance of remission and residual somatic symptoms in health-related quality of life among outpatients with major depressive disorder: a cross-sectional study. Health & Quality of Life Outcomes. 12, 188–188 (2013).
    1. Kung P. Y., Chou K. R., Lin K. C., Hsu H. W. & Chung M. H. Sleep disturbances in patients with major depressive disorder: incongruence between sleep log and actigraphy. Archives of psychiatric nursing. 29, 39–42 (2015).
    1. Sivertsen H., Bjorklof G. H., Engedal K., Selbaek G. & Helvik A. S. Depression and quality of life in older persons: a review. Dement Geriatr Cogn Disord. 40, 311–339 (2015).
    1. Li J. Correlation among resilience, social support and quality of life in patients with depression. Psychiatry journal. 4, 259–262 (2016).
    1. Hofmann S. G., Wu J. Q., Boettcher H. & Sturm J. Effect of pharmacotherapy for anxiety disorders on quality of life: a meta-analysis. Qual Life Res. 23, 1141–1153 (2014).
    1. Canu E. et al.. Structural connectivity in patients with major depression with or without generalized anxiety disorder comorbidity. Journal of Neurology. 262, 1255–65 (2015).
    1. Ishak W. W. et al.. Patient-reported outcomes of quality of life, functioning, and depressive symptom severity in major depressive disorder comorbid with panic disorder before and after ssri treatment in the star*d trial. Depress Anxiety. 31, 707–716 (2014).
    1. Gao K. et al.. Should an assessment of Axis I comorbidity be included in the initial diagnostic assessment of mood disorders? Role of QIDS-16-SR total score in predicting number of Axis I comorbidity. J Affect Disord. 148, 256–264 (2013).
    1. Shahzad N. et al.. Interactions of atenolol with alprazolam/escitalopram on anxiety, depression and oxidative stress. Pharmacol Biochem Behav. 117, 79–84 (2014).
    1. Glaus J. et al.. Associations between mood, anxiety or substance use disorders and inflammatory markers after adjustment for multiple covariates in a population-based study. J Psychiatr Res. 58, 36–45 (2014).
    1. Joshi G. et al.. Psychiatric comorbidity and functioning in a clinically referred population of adults with autism spectrum disorders: a comparativestudy. Journal of Autism & Developmental Disorders. 43, 1314–1325 (2013).
    1. Cramer V., Torgersen S. & Kringlen E. Mood disorders and quality of life. A community study. Cramer, V. 64, 58–62 (2010).
    1. Chung L., Pan A. W. & Hsiung P. C. Quality of life for patients with major depression in Taiwan:A model-based study of predictive factors. Chung, L. 168, 153–162 (2009).
    1. Bjelland I., Dahl A. A., Haug T. T. & Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 52, 69–77 (2002).
    1. Wang W., Chair S. Y., Thompson D. R. & Twinn S. F. A psychometric evaluation of the Chinese version of the Hospital Anxiety and Depression Scale in patients with coronary heart disease. J Clin Nurs. 18, 1908–1915 (2009).
    1. Kroenke K., Spitzer R. L. & Williams J. B. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 16, 606–613 (2001).
    1. Skevington S. M., Lotfy M. & O’Connell K. A. The World Health Organization’s WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res. 13, 299–310 (2004).
    1. Herrman H., Hawthorne G. & Thomas R. Quality of life assessment in people living with psychosis. Soc Psychiatry Psychiatr Epidemiol. 37, 510–518 (2002).
    1. Yao G., Chung C. W., Yu C. F. & Wang J. D. Development and verification of validity and reliability of the WHOQOL-BREF Taiwan version. J Formos Med Assoc. 101, 342–351 (2002).
    1. Dai W. et al.. Association between social support and recovery from post-traumatic stress disorder after flood: a 13-14 year follow-up study in Hunan, China. BMC Public Health. 16, 194 (2016).
    1. Trivedi M. H. et al.. Health-related quality of life in depression: a STAR* D report. Can J Psychiatry. 22, 43–55 (2010).
    1. Atalay H. Comorbidity of insomnia detected by the Pittsburgh sleep quality index with anxiety, depression and personality disorders. Isr J Psychiatry Relat Sci. 48, 54–59 (2011).
    1. Hayashino Y. et al.. Association between number of comorbid conditions, depression, and sleep quality using the Pittsburgh Sleep Quality Index: results from a population-based survey. Sleep Med. 11, 366–371 (2010).
    1. Tabrizi F. M. & Radfar M. Fatigue, sleep quality, and disability in relation to quality of life in multiple sclerosis. Int J MS Care. 17, 268–274 (2015).
    1. Tsai P. S. et al.. Psychometric evaluation of the Chinese version of the Pittsburgh Sleep Quality Index (CPSQI) in primary insomnia and control subjects. Qual Life Res. 14, 1943–1952 (2005).

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera